Haemonetics (HAE) Total Liabilities (2010 - 2026)

Haemonetics has reported Total Liabilities for 17 years, with the latest figure at $1.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 1.87% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (down 1.87% YoY), and the FY2026 full-year result was $1.6 billion, down 1.87% from the prior year.
• Total Liabilities for Q1 2026 stood at $1.6 billion, up from $1.6 billion in the prior quarter.
• The five-year high for Total Liabilities was $1.6 billion in Q3 2024, with the low at $1.1 billion in Q3 2022.
• Average Total Liabilities over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2023.
• Peak annual rise in Total Liabilities reached 83.77% in 2022, while the deepest fall reached 6.0% in 2022.
• Tracing HAE's Total Liabilities over 5 years: stood at $1.1 billion in 2022, then climbed by 14.07% to $1.3 billion in 2023, then climbed by 29.22% to $1.6 billion in 2024, then dropped by 2.77% to $1.6 billion in 2025, then advanced by 1.28% to $1.6 billion in 2026.
• The last three Total Liabilities figures came in at $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison